Neoadjuvant chemotherapy with gemcitabine-based regimens improves the prognosis of node positive resectable pancreatic head cancer.
Tajima H, Ohta T, Okazaki M, Yamaguchi T, Ohbatake Y, Okamoto K, Nakanuma S, Kinoshita J, Makino I, Nakamura K, Miyashita T, Takamura H, Ninomiya I, Fushida S, Nakamura H.
Tajima H, et al. Among authors: okazaki m.
Mol Clin Oncol. 2019 Aug;11(2):157-166. doi: 10.3892/mco.2019.1867. Epub 2019 May 24.
Mol Clin Oncol. 2019.
PMID: 31281650
Free PMC article.